SCHEMBL2615411

SCHEMBL2615411

O=C1CN=C(c2ccc(F)cc2)c2ccccc2N1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 5/20 0.78
GABRA5 P31644 5/20 0.78
GABRA3 P34903 5/20 0.78
GABRA2 P47869 5/20 0.78
GABRB2 P47870 4/20 0.78
GABRG2 P18507 3/20 0.78
GABRB3 P28472 3/20 0.78
JAK2 O60674 1/20 0.59
RET P07949 1/20 0.59
MAP2K1 Q02750 1/20 0.59
MAP4K2 Q12851 1/20 0.59
PDE4D Q08499 2/20 0.56
CNR1 P21554 1/20 0.56
NTSR1 P30989 1/20 0.56
OPRK1 P41145 1/20 0.56
LMNA P02545 2/20 0.52
HPGD P15428 1/20 0.51
GABRP O00591 1/20 0.48
GABRD O14764 1/20 0.48
GABRB1 P18505 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2615408 1.00 GABRA1 (0.78) GABRA1GABRA5GABRA3GABRA2GABRB2
Ro-052921 SCHEMBL29979594 0.88 GABRA1 (1.00) GABRA1GABRA5GABRA3GABRA2GABRB2
Ro-052921 SCHEMBL1365706 0.88 GABRA1 (1.00) GABRA1GABRA5GABRA3GABRA2GABRB2
SCHEMBL11543658 0.85 GABRA1 (0.78) GABRA1GABRA5GABRA3GABRA2GABRB2
SCHEMBL2631571 0.85 GABRA1 (0.64) GABRA1GABRA5GABRA3GABRA2GABRB2
SCHEMBL27587130 0.85 GABRA1 (0.72) GABRA1GABRA5GABRA3GABRA2GABRB2
SCHEMBL7832057 0.85 GABRA1 (0.72) GABRA1GABRA5GABRA3GABRA2GABRB2
Ro-053061 SCHEMBL2615407 0.83 PDE4D (0.71) GABRA1GABRA5GABRA3GABRA2GABRB2
Ro-053061 SCHEMBL2615409 0.83 PDE4D (0.71) GABRA1GABRA5GABRA3GABRA2GABRB2
SCHEMBL8547651 0.82 GABRA1 (0.73) GABRA1GABRA5GABRA3GABRA2GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120095217-A1 FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2012-04-19 US disclosed
US-20120095217-A1 FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2012-04-19 US disclosed
WO-2010081036-A2 FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2010-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095217-A1 FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF FLI1, CDC73, FOS GABRA1 1880/4885GABRA5 2062/4885GABRA3 1497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.